Obermair calls for his fellow gynecological cancer surgeons to join him in interrogating current standards of practice.

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain ...

MSD's Sac-TMT presents as a strong competitor to AstraZeneca/Daichii Sankyo's Dato-DXd based on cross-trial comparisons.

Gynecological cancer affects millions of people around the world every year. Here’s what you need to know about symptoms, ...

Even for Merck’s oncology powerhouse Keytruda, the emerging role of immunotherapies in gynecological cancer treatment ...

The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed ...

The FDA has lifted the partial clinical hold on Zentalis Pharmaceuticals' azenosertib studies. Zentalis plans to work with ...

The late former owner of London's luxury department store Harrods has been accused of sexually assaulting dozens of women, ...

A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an ...

LONDON — Mohamed Al Fayed would tell his female staff to call him “Papa.” ...

J&J's proposed settlement would pay talc claimants about $10 billion over 25 years. The present value of the settlement is ...